122 related articles for article (PubMed ID: 37336688)
41. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
Yu Y; Chen D; Zhao Y; Zhu J; Dong X
Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
[TBL] [Abstract][Full Text] [Related]
42. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
43. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
Yang G; Lee HE; Lee JY
Sci Rep; 2016 Apr; 6():24399. PubMed ID: 27075683
[TBL] [Abstract][Full Text] [Related]
44. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
45. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
47. Deletion of Smurf1 attenuates liver steatosis via stabilization of p53.
Lin W; Zhang X; Zhang C; Li L; Zhang J; Xie P; Zhan Y; An W
Lab Invest; 2022 Oct; 102(10):1075-1087. PubMed ID: 35672379
[TBL] [Abstract][Full Text] [Related]
48. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
Akie TE; Liu L; Nam M; Lei S; Cooper MP
PLoS One; 2015; 10(5):e0125617. PubMed ID: 25933096
[TBL] [Abstract][Full Text] [Related]
49. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
[TBL] [Abstract][Full Text] [Related]
50. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice.
Yu CJ; Wang QS; Wu MM; Song BL; Liang C; Lou J; Tang LL; Yu XD; Niu N; Yang X; Zhang BL; Qu Y; Liu Y; Dong ZC; Zhang ZR
Hepatology; 2018 Nov; 68(5):1769-1785. PubMed ID: 29704259
[TBL] [Abstract][Full Text] [Related]
51. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
Zhu W; Feng PP; He K; Li SW; Gong JP
Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
[TBL] [Abstract][Full Text] [Related]
52. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.
Zhao P; Han SN; Arumugam S; Yousaf MN; Qin Y; Jiang JX; Torok NJ; Chen Y; Mankash MS; Liu J; Li J; Iwakiri Y; Ouyang X
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G387-G397. PubMed ID: 31411894
[TBL] [Abstract][Full Text] [Related]
53. Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels.
Quezada N; Valencia I; Torres J; Maturana G; Cerda J; Arab JP; Fuentes JJ; Pinto C; Turiel D; Cortés V
BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33941551
[TBL] [Abstract][Full Text] [Related]
54. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
55. Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity.
Liu X; Wang K; Wang L; Kong L; Hou S; Wan Y; Ma C; Chen J; Xing X; Xing C; Jiang Q; Zhao Q; Cui B; Huang Z; Li P
Hepatology; 2023 Aug; 78(2):562-577. PubMed ID: 35931467
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
Samuel VT; Liu ZX; Wang A; Beddow SA; Geisler JG; Kahn M; Zhang XM; Monia BP; Bhanot S; Shulman GI
J Clin Invest; 2007 Mar; 117(3):739-45. PubMed ID: 17318260
[TBL] [Abstract][Full Text] [Related]
57. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
58. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
59. Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway.
Xiao J; Liu Y; Xing F; Leung TM; Liong EC; Tipoe GL
Eur J Nutr; 2016 Jun; 55(4):1465-77. PubMed ID: 26133299
[TBL] [Abstract][Full Text] [Related]
60. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
